Skip to content

Endovascular repair for thoracic aortic unfavorable remodeling early after open surgery for type A aortic dissection: a multicenter, prospective cohort study

Endovascular repair for thoracic aortic unfavorable remodeling early after open surgery for type A aortic dissection: a multicenter, prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062481
Enrollment
Unknown
Registered
2022-08-08
Start date
2022-08-08
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unfavorable thoracic aortic remodeling early after open surgery for Stanford A aortic dissection

Interventions

Treatment group:Endovascular repair
Control group:No special surgical intervention

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18 and 80 years old; 2. Patients with Stanford type A aortic dissection within 90 days of onset and 30 days after Sun's operation; 3. No aortic surgery history other than Sun's operation; 4. Residual aortic dissection at the distal end of the elephant trunk stent and its involvement to the ostia of the celiac trunk; 5. The volume of the thoracic aortic false lumen from the end of the trunk stent to the horizontal segment of the diaphragm > 50% of the segemental aortic volume; 6. The thoracic descending aorta with residual tear; 7. The left subclavian artery has been revascularized; 8. The life expectancy of the patient is more than 12 months; 9. The patient can understand the purpose of the trial. Volunteer to participate and sign informed consent; 10. Patients are willing to follow-up evaluation according to the requirements of clinical trial program.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating patients; 2. Chronic aortic dissection (onset > 3 months); 3. Patients who are not suitable for endovascular repairs, such as no suitable vascular approach, allergy to nickel-titanium alloy, severe renal insufficiency or may have severe reaction to contrast media; 4. Patients with myocardial infarction or cerebrovascular accident within 3 months; 5. Patients with poor compliance; 6. Patients who participated in other clinical studies at the same time.

Design outcomes

Primary

MeasureTime frame
All-cause mortality;Reintervention rate;

Secondary

MeasureTime frame
Organ ischemia and dysfunction;Stent-related complications;Morphological index;

Countries

China

Contacts

Public ContactJia Hu

West China Hospital, Sichuan University

1725194@qq.com+86 18682560211

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026